With the first year of Horizon Europe behind us, it is time to take stock of what works and what does not. One thing is certain: building a strong and united Europe that can apply research and innovation to pressing societal problems is more relevant than ever
The Innovative Medicines Initiative’s European Lead Factory has helped identify two drug candidates for cancer treatment that have now progressed to clinical testing.
The sector could make a big contribution to the green and digital transitions, but it needs better access to EU R&D and to be routinely involved in multidisciplinary research projects
At Paris open science conference, EU research leaders back the Commission’s plan to overhaul the way funding agencies assess the scientific standing of individual researchers
As Science|Business celebrates the 1000th issue of its newsletter this month, here we republish a June 2017 white paper on economic research into public R&D funding – an issue especially relevant today, as Horizon Europe gathers speed
Researchers awarded ERC grants still don’t know if the UK will associate to Horizon Europe in time for them to sign the grant agreements. Now, they are being enticed to relocate to EU universities
As the European Parliament begins internal talks on next year’s budget, some MEPs warn they might lose again in the battle with member states on using unspent research money
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.